Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company's products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporation's under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Generex Biotechnology Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Generex Biotechnology Corp market cap is $100.00.
What is the 52-week high for Generex Biotechnology Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Generex Biotechnology Corp 52 week high is $0.0804 as of April 23, 2024.
What is the 52-week low for Generex Biotechnology Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Generex Biotechnology Corp 52 week low is $0.00 as of April 23, 2024.
What was Generex Biotechnology Corp stock price yesterday?
Generex Biotechnology Corp stock price yesterday was $0.000001.
What is the 50-day moving average of Generex Biotechnology Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Generex Biotechnology Corp 50-day moving average is $0.0001.